EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CRIF1 siRNA-Encapsulated PLGA Nanoparticles Suppress Tumor Growth in MCF-7 Human Breast Cancer Cells

Shuyu Piao iD, Ikjun Lee, Seonhee Kim, Hyewon Park, Harsha Nagar, Su-Jeong Choi, Giang-Huong Vu, Minsoo Kim, Eun-Ok Lee, Byeong-Hwa Jeon iD, Dong Woon Kim iD, Youngduk Seo iD und 1 weitere

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24087453 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Shuyu Piao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology & Medical Science, School of Medicine, Chungnam National University, Daejeon 35015, Republic of Korea. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Basic Science Research Program through the National Research Foundation of Korea (NRF), Ministry of Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondrial oxidative phosphorylation (OXPHOS) system dysfunction in cancer cells has been exploited as a target for anti-cancer therapeutic intervention. The downregulation of CR6-interacting factor 1 (CRIF1), an essential mito-ribosomal factor, can impair mitochondrial function in various cell types. In this study, we investigated whether CRIF1 deficiency induced by siRNA and siRNA nanoparticles could suppress MCF-7 breast cancer growth and tumor development, respectively. Our results showed that CRIF1 silencing decreased the assembly of mitochondrial OXPHOS complexes I and II, which induced mitochondrial dysfunction, mitochondrial reactive oxygen species (ROS) production, mitochondrial membrane potential depolarization, and excessive mitochondrial fission. CRIF1 inhibition reduced p53-induced glycolysis and apoptosis regulator (TIGAR) expression, as well as NADPH synthesis, leading to additional increases in ROS production. The downregulation of CRIF1 suppressed cell proliferation and inhibited cell migration through the induction of G0/G1 phase cell cycle arrest in MCF-7 breast cancer cells. Similarly, the intratumoral injection of CRIF1 siRNA-encapsulated PLGA nanoparticles inhibited tumor growth, downregulated the assembly of mitochondrial OXPHOS complexes I and II, and induced the expression of cell cycle protein markers (p53, p21, and p16) in MCF-7 xenograft mice. Thus, the inhibition of mitochondrial OXPHOS protein synthesis through CRIF1 deletion destroyed mitochondrial function, leading to elevated ROS levels and inducing antitumor effects in MCF-7 cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsAnimalsFemaleHumansMiceApoptosisApoptosis Regulatory ProteinsCell Cycle ProteinsMCF-7 CellsPhosphoric Monoester HydrolasesReactive Oxygen SpeciesRNA, Small InterferingTumor Suppressor Protein p53Polyethylene GlycolsNanoparticles

Stichwörter der Autor:innen

CRIF1MCF-7 cellsPLGAmitochondrial dysfunctionnanoparticle

Substanzen

Apoptosis Regulatory ProteinsCell Cycle ProteinsCrif1 protein, mousePhosphoric Monoester HydrolasesReactive Oxygen SpeciesRNA, Small InterferingTIGAR protein, mouseTumor Suppressor Protein p53Polyethylene Glycols

Autor:innen und Institutionen

  • Department of Physiology & Medical Science, School of Medicine, Chungnam National University, Daejeon 35015, Republic of Korea.
  • Department of Anatomy and Cell Biology & Medical Science, School of Medicine, Chungnam National University, Daejeon 35015, Republic of Korea.
  • Department of Nuclear Medicine, Chungnam National University Sejong Hospital, Sejong 30099, Republic of Korea.

ORCID-Profile: Shuyu Piao, Byeong-Hwa Jeon, Dong Woon Kim, Youngduk Seo, Cuk-Seong Kim

Förderung

  • National Research Foundation of Korea
  • Basic Science Research Program through the National Research Foundation of Korea (NRF)
  • Ministry of Education
  • Chungnam National University

Zitieren

APA

Piao, S., Lee, I., Kim, S., Park, H., Nagar, H., Choi, S. J., Vu, G. H., Kim, M., Lee, E. O., Jeon, B. H., Kim, D. W., Seo, Y., & Kim, C. S. (2023). CRIF1 siRNA-Encapsulated PLGA Nanoparticles Suppress Tumor Growth in MCF-7 Human Breast Cancer Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24087453

Vancouver

Piao S, Lee I, Kim S, Park H, Nagar H, Choi SJ, et al. CRIF1 siRNA-Encapsulated PLGA Nanoparticles Suppress Tumor Growth in MCF-7 Human Breast Cancer Cells. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24087453

BibTeX
@article{Piao2023,
  author = {Piao, Shuyu and Lee, Ikjun and Kim, Seonhee and Park, Hyewon and Nagar, Harsha and Choi, Su-Jeong and Vu, Giang-Huong and Kim, Minsoo and Lee, Eun-Ok and Jeon, Byeong-Hwa and Kim, Dong Woon and Seo, Youngduk and Kim, Cuk-Seong},
  title = {CRIF1 siRNA-Encapsulated PLGA Nanoparticles Suppress Tumor Growth in MCF-7 Human Breast Cancer Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24087453}
}
Kostenlos starten →